ArticleAlimentary pharmacology & therapeutics2025
Coronary Artery Disease and Major Adverse Cardiovascular Events in People With Hepatic Steatosis at Low Atherosclerotic Cardiovascular Disease Risk.
Julia Karady et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.